Stay updated on Pirfenidone in COVID-19 Clinical Trial
Sign up to get notified when there's something new on the Pirfenidone in COVID-19 Clinical Trial page.

Latest updates to the Pirfenidone in COVID-19 Clinical Trial page
- Check4 days agoChange DetectedThe screenshots show mainly formatting adjustments with no changes to core study details or how to interact with the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check11 days agoNo Change Detected
- Check32 days agoChange DetectedUpgrade from revision v3.0.2 to v3.2.0 and insertion of a government-operating-status notice; two numeric entries likely identifiers were added.SummaryDifference3%

- Check34 days agoChange DetectedNo significant changes to core content or important data; only a version upgrade (v3.0.2 removed, v3.1.0 added) and three numbers added.SummaryDifference0.1%

- Check48 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; Back to Top link removed (minor UI change).SummaryDifference0.2%

- Check55 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.2%

- Check62 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location, as well as the introduction of MedlinePlus related topics on pneumonia. However, several key medical terms and categories have been removed, including various drug classifications and previous location details.SummaryDifference2%

Stay in the know with updates to Pirfenidone in COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pirfenidone in COVID-19 Clinical Trial page.